FFTY vs. XPH ETF Comparison

Comparison of Innovator IBD 50 Fund ETF (FFTY) to SPDR S&P Pharmaceuticals ETF (XPH)
FFTY

Innovator IBD 50 Fund ETF

FFTY Description

The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in companies included in the IBD® 50 Index. It is actively managed. Under normal circumstances, the fund will invest in a portfolio of U.S.-listed, exchange-traded equities. FFTY picks 50 leading growth companies that trade on US exchanges, potentially including ADRs. After screening out securities with extreme recent price movements, the universe is ranked by a composite of 11 different fundamental and technical metrics. The top 50 stocks are weighted in tiers, with more weight given to higher-ranking companies. Components of the index are reviewed on a weekly basis. Based on market-wide technical signals, FFTY may substitute half of its equity portfolio with Treasury bills. The index will remain half equity, half T-bills until a reversal signal occurs. Its worth noting that the funds high-turnover strategy could lead to poor tracking and/or taxable capital gains payouts.

Grade (RS Rating)

Last Trade

$30.96

Average Daily Volume

79,149

Number of Holdings *

50

* may have additional holdings in another (foreign) market
XPH

SPDR S&P Pharmaceuticals ETF

XPH Description The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Grade (RS Rating)

Last Trade

$46.57

Average Daily Volume

60,972

Number of Holdings *

44

* may have additional holdings in another (foreign) market
Performance
Period FFTY XPH
30 Days 14.45% 0.69%
60 Days 14.88% 6.08%
90 Days 17.01% 5.92%
12 Months 37.94% 28.75%
1 Overlapping Holdings
Symbol Grade Weight in FFTY Weight in XPH Overlap
HROW D 2.95% 1.17% 1.17%
FFTY Overweight 49 Positions Relative to XPH
Symbol Grade Weight
HIMS B 3.77%
POWL C 3.6%
NVDA C 3.59%
VRT B 3.58%
STRL B 3.57%
FIX A 3.52%
PLTR B 3.47%
ATAT C 3.46%
DOCS C 3.28%
ARM D 3.22%
CLS B 3.21%
YOU D 3.09%
NTRA B 3.05%
BWIN D 3.0%
ANET C 3.0%
EME C 2.99%
DUOL A 2.92%
BGNE D 2.79%
ADMA B 2.77%
IOT A 2.07%
MNDY C 2.05%
CWAN B 2.03%
RCL A 2.01%
FTAI B 2.01%
RYAN B 1.99%
LNTH D 1.99%
IBKR A 1.99%
AXON A 1.99%
ONON A 1.92%
AFRM B 1.12%
TT A 1.0%
MELI D 1.0%
VITL D 0.99%
TW A 0.99%
NOW A 0.99%
FOUR B 0.99%
TVTX B 0.98%
HWM A 0.97%
NFLX A 0.96%
PACS F 0.51%
KVYO C 0.51%
FTNT C 0.51%
ALNY D 0.51%
AGX B 0.5%
DY D 0.49%
DECK A 0.49%
AMSC B 0.49%
TOST B 0.48%
ZETA D 0.46%
FFTY Underweight 43 Positions Relative to XPH
Symbol Grade Weight
CORT B -4.96%
LBPH A -4.12%
BMY B -4.11%
ITCI C -4.01%
JAZZ B -3.94%
VTRS A -3.73%
AXSM B -3.59%
EWTX C -3.42%
CTLT B -3.41%
ELAN D -3.35%
PRGO B -3.35%
RPRX D -3.18%
JNJ D -3.17%
ZTS D -3.15%
PFE D -3.07%
LLY F -2.94%
MRK F -2.93%
TARS B -2.81%
OGN D -2.58%
SAVA D -2.57%
ARVN D -2.53%
PBH A -2.5%
SUPN C -2.15%
AMPH D -2.02%
PCRX C -1.91%
LGND B -1.77%
ANIP F -1.54%
COLL F -1.48%
OCUL D -1.44%
AMRX C -1.33%
MNMD C -1.23%
HRMY D -1.22%
WVE C -1.17%
INVA D -0.98%
EYPT F -0.94%
LQDA D -0.89%
PLRX F -0.87%
FULC F -0.85%
ELVN D -0.64%
NUVB C -0.6%
EOLS D -0.52%
PHAT F -0.48%
XERS B -0.46%
Compare ETFs